{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:17:31Z","timestamp":1784168251110,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01822-7","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:09:40Z","timestamp":1748056180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of tumor-infiltrating lymphocytes and depth of invasion in T1 bladder cancer: a retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0537-3127","authenticated-orcid":false,"given":"Busra","family":"Yaprak Bayrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7411-6720","authenticated-orcid":false,"given":"Hatice Nese","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-4662","authenticated-orcid":false,"given":"Kerem","family":"Teke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1602-0443","authenticated-orcid":false,"given":"Hakk\u0131can","family":"Yuvak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-4588","authenticated-orcid":false,"given":"Ozdal","family":"Dillioglugil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"1","key":"1822_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00428-020-02808-6","volume":"477","author":"MR Raspollini","year":"2020","unstructured":"Raspollini MR, Montironi R, Mazzucchelli R, Cimadamore A, Cheng L, Lopez-Beltran A. pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging. Virchows Arch. 2020;477(1):3\u201316. https:\/\/doi.org\/10.1007\/s00428-020-02808-6","journal-title":"Virchows Arch"},{"issue":"5","key":"1822_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.5858\/arpa.2023-0044-OA","volume":"148","author":"S Sato","year":"2024","unstructured":"Sato S, Yanagisawa T, Miki J, Hayashida Y, Okada Y, Iwatani K, et al. pT1 subclassification predicts Progression-Free survival in En bloc resection of bladder tumor specimens. Arch Pathol Lab Med. 2024;148(5):573\u201380. https:\/\/doi.org\/10.5858\/arpa.2023-0044-OA","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1822_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/bju.16298","volume":"134","author":"M Haas","year":"2024","unstructured":"Haas M, Engelmann SU, Mayr R, Gossler C, Pickl C, K\u00e4lble S, et al. A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer. BJU Int. 2024;134(2):249\u201357. https:\/\/doi.org\/10.1111\/bju.16298","journal-title":"BJU Int"},{"issue":"1","key":"1822_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.euf.2016.06.004","volume":"4","author":"R Colombo","year":"2018","unstructured":"Colombo R, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, et al. Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 High-Grade bladder Cancer. Eur Urol Focus. 2018;4(1):87\u201393. https:\/\/doi.org\/10.1016\/j.euf.2016.06.004","journal-title":"Eur Urol Focus"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejca.2018.12.010","volume":"108","author":"M Rouanne","year":"2019","unstructured":"Rouanne M, Betari R, Radulescu C, Goubar A, Signolle N, Neuzillet Y, et al. Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer. Eur J Cancer. 2019;108:111\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.010","journal-title":"Eur J Cancer"},{"issue":"21","key":"1822_CR6","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.3390\/ijms21218407","volume":"21","author":"S H\u00fclsen","year":"2020","unstructured":"H\u00fclsen S, Lippolis E, Ferrazzi F, Otto W, Distel L, Fietkau R, et al. High stroma T-Cell infiltration is associated with better survival in stage pT1 bladder Cancer. Int J Mol Sci. 2020;21(21):8407. https:\/\/doi.org\/10.3390\/ijms21218407","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1822_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/cancers15041205","volume":"15","author":"J Drachneris","year":"2023","unstructured":"Drachneris J, Rasmusson A, Morkunas M, Fabijonavicius M, Cekauskas A, Jankevicius F, et al. CD8\u2009+\u2009Cell density gradient across the tumor Epithelium-Stromal interface of Non-Muscle invasive papillary urothelial carcinoma predicts Recurrence-Free survival after BCG immunotherapy. Cancers (Basel). 2023;15(4):1205. https:\/\/doi.org\/10.3390\/cancers15041205","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1822_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","volume":"44","author":"F Brimo","year":"2013","unstructured":"Brimo F, Wu C, Zeizafoun N, Tanguay S, Aprikian A, Mansure JJ, et al. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion. Hum Pathol. 2013;44(1):95\u2013102. https:\/\/doi.org\/10.1016\/j.humpath.2012.04.020","journal-title":"Hum Pathol"},{"issue":"8","key":"1822_CR9","first-page":"361","volume":"36","author":"EE van de Fransen","year":"2018","unstructured":"van de Fransen EE, Otto W, Hartmann A, Bertz S, Mayr R, Br\u00fcndl J, et al. Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer. Urol Oncol. 2018;36(8):361.e7-361.e13.","journal-title":"Urol Oncol"},{"issue":"1","key":"1822_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","volume":"42","author":"MZ Leivo","year":"2018","unstructured":"Leivo MZ, Sahoo D, Hamilton Z, Mirsadraei L, Shabaik A, Parsons JK, et al. Analysis of T1 bladder Cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion. Am J Surg Pathol. 2018;42(1):e1\u201310. https:\/\/doi.org\/10.1097\/PAS.0000000000000964","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1822_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/bju.16293","volume":"133","author":"R Contieri","year":"2024","unstructured":"Contieri R, Tan WS, Grajales V, Hensley PJ, Martini A, Bree K, et al. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU Int. 2024;133(6):733\u201341. https:\/\/doi.org\/10.1111\/bju.16293","journal-title":"BJU Int"},{"issue":"1","key":"1822_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pathol.2020.09.014","volume":"53","author":"A Lopez-Beltran","year":"2021","unstructured":"Lopez-Beltran A, Cheng L. Stage T1 bladder cancer: diagnostic criteria and pitfalls. Pathology. 2021;53(1):67\u201385. https:\/\/doi.org\/10.1016\/j.pathol.2020.09.014","journal-title":"Pathology"},{"issue":"9","key":"1822_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5858\/arpa.2021-0175-OA","volume":"146","author":"A Budina","year":"2022","unstructured":"Budina A, Farahani SJ, Lal P, Nayak A. Subcategorization of T1 bladder Cancer on biopsy and transurethral resection specimens for predicting progression. Arch Pathol Lab Med. 2022;146(9):1131\u20139. https:\/\/doi.org\/10.5858\/arpa.2021-0175-OA","journal-title":"Arch Pathol Lab Med"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"704902","DOI":"10.3389\/fsurg.2021.704902","volume":"8","author":"AD Asimakopoulos","year":"2021","unstructured":"Asimakopoulos AD, Colalillo G, Telesca R, Mauriello A, Miano R, Di Stasi SM, et al. T1 bladder cancer: comparison of the prognostic impact of two substaging systems on disease recurrence and progression and suggestion of a novel nomogram. Front Surg. 2021;8:704902. https:\/\/doi.org\/10.3389\/fsurg.2021.704902","journal-title":"Front Surg"},{"issue":"1","key":"1822_CR15","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000002077","volume":"48","author":"GP Paner","year":"2024","unstructured":"Paner P GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, et al. International society of urological pathology (ISUP) consensus conference on current issues in bladder cancer. Working group 2: grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and Non-Urothelial carcinomas. Am J Surg Pathol. 2024;48(1):e11\u201323. https:\/\/doi.org\/10.1097\/PAS.0000000000002077","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1822_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11255-020-02772-9","volume":"53","author":"M Yasui","year":"2021","unstructured":"Yasui M, Ohta JI, Aoki S, Tajirika H, Terao H, Funahashi M, et al. Prognosis of patients with T1 bladder cancer after En bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa. Int Urol Nephrol. 2021;53(6):1105\u20139. https:\/\/doi.org\/10.1007\/s11255-020-02772-9","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1822_CR17","doi-asserted-by":"publisher","first-page":"17981","DOI":"10.1038\/s41598-021-97500-3","volume":"11","author":"M Eckstein","year":"2021","unstructured":"Eckstein M, Kimmel C, Bruendl J, Weber F, Denzinger S, Gierth M, et al. Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer. Sci Rep. 2021;11(1):17981. https:\/\/doi.org\/10.1038\/s41598-021-97500-3","journal-title":"Sci Rep"},{"issue":"9","key":"1822_CR18","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.3390\/ijms25094776","volume":"25","author":"J Drachneris","year":"2024","unstructured":"Drachneris J, Morkunas M, Fabijonavicius M, Cekauskas A, Jankevicius F, Laurinavicius A. Spatial distribution of macrophage and lymphocyte subtypes within tumor microenvironment to predict recurrence of Non-Muscle-Invasive papillary urothelial carcinoma after BCG immunotherapy. Int J Mol Sci. 2024;25(9):4776. https:\/\/doi.org\/10.3390\/ijms25094776","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1822_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.urolonc.2023.08.012","volume":"41","author":"AH Civriz","year":"2023","unstructured":"Civriz AH, Teke K, Akdas EM, Dillioglugil O, Vural C, Yaprak Bayrak B. The prognostic value of expressions of STAT3, PD-L1, and PD-L2 in Ta\/T1 urothelial carcinoma before and after BCG treatment. Urol Oncol. 2023;41(12):486..e1-486.e13.","journal-title":"Urol Oncol"},{"issue":"6","key":"1822_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1470-2045(24)00178-5","volume":"25","author":"A Necchi","year":"2024","unstructured":"Necchi A, Roumigui\u00e9 M, Kamat AM, Shore ND, Boormans JL, Esen AA, et al. Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2024;25(6):720\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(24)00178-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"1822_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, Chang SS, Holmes R, James AC, et al. Diagnosis and treatment of Non-Muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol. 2024;211(4):533\u20138. https:\/\/doi.org\/10.1097\/JU.0000000000003846","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01822-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T15:03:13Z","timestamp":1748098993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01822-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01822-7","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethical Committee of Non-invasive Clinical Research of Kocaeli University (Decision No: KU GOKAEK-2024\/18.22, Project No: 2024\/456). This study was conducted according to the Helsinki principles, patients signed informed consent for participation, and nothing invasive of patients\u2019 privacy was done. Written informed consent was obtained from patients for publication of this original article and all accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}